Body Dysmorphic Disorder

Body dysmorphic disorder (BDD) was not recognized as a unique diagnosis until 1987. Since that time, there has been a marked increase in systematic research into the characterization, comorbidities, and treatment of BDD. The essential feature of BDD is preoccupation with an imagined defect in appearance in a normal-appearing person or a markedly excessive concern about a slight imperfection (Allen and Hollander, 2000). The preoccupation must cause significant distress or impairment in functioning and must not be confined to another disorder, for example, preoccupation with obesity in anorexia nervosa. BDD is relatively common and has been reported to affect 1.9 percent of nonclinical samples (Rich et al., 1992) and 12 percent of psychiatric outpatients (Zimmerman et al., 1998). Similar to OCD, serotonin reuptake inhibitors

(SRIs) (such as clomipramine, fluoxetine, and fluvoxamine) demonstrate specific efficacy in the treatment of BDD (Hollander et al., 1989; Phillips et al., 1998). Although only a few controlled studies on psychotherapy for patients with BDD have been done, cognitive-behavioral therapy has been found to be effective (Grant and Cash, 1995; Neziroglu et al., 1996).

Was this article helpful?

0 0
Weight Loss All Star

Weight Loss All Star

Are you looking to lose weight or even just tone up? What is stopping you from having the body you want and help you feel great at the same time? I created Weight Loss All-Star for all those wanting to lose weight, and keep the weight off. I know how hard it is to do diets and stick with them, and get the motivation to get up and exercise.

Get My Free Ebook


Post a comment